Stage I non-small cell lung cancer stratification by using a model-based clustering algorithm with covariates
Lung cancer is currently the leading cause of cancer deaths. Among various subtypes, the number of patients diagnosed with stage I non-small cell lung cancer (NSCLC), particularly adenocarcinoma, has been increasing. It is estimated that 30 - 40\% of stage I patients will relapse, and 10 - 30\% will...
Saved in:
Main Authors | , |
---|---|
Format | Journal Article |
Language | English |
Published |
05.04.2020
|
Subjects | |
Online Access | Get full text |
DOI | 10.48550/arxiv.2004.02333 |
Cover
Loading…
Summary: | Lung cancer is currently the leading cause of cancer deaths. Among various
subtypes, the number of patients diagnosed with stage I non-small cell lung
cancer (NSCLC), particularly adenocarcinoma, has been increasing. It is
estimated that 30 - 40\% of stage I patients will relapse, and 10 - 30\% will
die due to recurrence, clearly suggesting the presence of a subgroup that could
be benefited by additional therapy. We hypothesize that current attempts to
identify stage I NSCLC subgroup failed due to covariate effects, such as the
age at diagnosis and differentiation, which may be masking the results. In this
context, to stratify stage I NSCLC, we propose CEM-Co, a model-based clustering
algorithm that removes/minimizes the effects of undesirable covariates during
the clustering process. We applied CEM-Co on a gene expression data set
composed of 129 subjects diagnosed with stage I NSCLC and successfully
identified a subgroup with a significantly different phenotype (poor
prognosis), while standard clustering algorithms failed. |
---|---|
DOI: | 10.48550/arxiv.2004.02333 |